Carlson; Rolf I.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Carlson; Rolf I..The latest application filed is for "anti-chi3l1 antibodies for the detection and/or treatment of nonalcoholic fatty liver disease/ nonalcoholic steatonhepatitis and subsequent complications".

Company Profile

1.8.14

Carlson; Rolf I. - Boston MA
Carlson; Rolf I. - Providence RI
Carlson; Rolf I. - Waban MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Anti-chi3l1 Antibodies For The Detection And/or Treatment Of Nonalcoholic Fatty Liver Disease/ Nonalcoholic Steatonhepatitis And Subsequent Complications App 20220002440 - Wands; Jack R. ; et al.	2022-01-06
Anti-CHI3L1 antibodies for the detection and/or treatment of nonalcoholic fattly liver disease/nonalcoholic steatonhepatitis and subsequent complications Grant 11,155,638 - Wands , et al. October 26, 2	2021-10-26
Anti-chi3l1 Antibodies For The Detection And/or Treatment Of Nonalcoholic Fattly Liver Disease/ Nonalcoholic Steatonhepatitis And Subsequent Complications App 20210230302 - Wands; Jack R. ; et al.	2021-07-29
Targeting Aspartate Beta-hydroxylase Suppresses Tumor Malignancy And Metastasis App 20210052561 - Wands; Jack R. ; et al.	2021-02-25
Diagnosis And Treatment Of Malignant Neoplasms App 20100144837 - Wands; Jack R. ; et al.	2010-06-10
Diagnosis And Treatment Of Malignant Neoplasms App 20100136581 - Wands; Jack R. ; et al.	2010-06-03
Methods of inhibiting metastases Grant 7,122,541 - Wands , et al. October 17, 2	2006-10-17
Diagnosis and treatment of malignant neoplasms App 20060211058 - Wands; Jack R. ; et al.	2006-09-21
Diagnosis and treatment of malignant neoplasms Grant 7,094,556 - Wands , et al. August 22, 2	2006-08-22
Methods of inhibiting metastases App 20050032785 - Wands, Jack R. ; et al.	2005-02-10
Diagnosis and treatment of malignant neoplasms Grant 6,815,415 - Wands , et al. November 9, 2	2004-11-09
Diagnosis and treatment of malignant neoplasms Grant 6,812,206 - Wands , et al. November 2, 2	2004-11-02
Diagnosis and treatment of malignant neoplasms Grant 6,797,696 - Wands , et al. September 28, 2	2004-09-28
Diagnosis and treatment of malignant neoplasms Grant 6,783,758 - Wands , et al. August 31, 2	2004-08-31
Methods of inhibiting metastases Grant 6,753,328 - Wands , et al. June 22, 2	2004-06-22
Methods of inhibiting metastases App 20030069229 - Wands, Jack R. ; et al.	2003-04-10
Diagnosis And Treatment Of Malignant Neoplasms App 20030031670 - WANDS, JACK R. ; et al.	2003-02-13
Diagnosis and treatment of malignant neoplasms App 20020146421 - Wands, Jack R. ; et al.	2002-10-10
Diagnosis and treatment of malignant neoplasms App 20020122802 - Wands, Jack R. ; et al.	2002-09-05
Diagnosis and treatment of malignant neoplasms App 20020114811 - Wands, Jack R. ; et al.	2002-08-22
Diagnosis and treatment of malignant neoplasms statement as to federally sponsored research App 20020114810 - Wands, Jack R. ; et al.	2002-08-22
Diagnosis and treatment of malignant neoplasms App 20020102263 - Wands, Jack R. ; et al.	2002-08-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.